$CLRI
Cleartronic, Inc. Stock $clri

$clri Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000109181816000214 Filed on January 13, 2016

Income Statement

Concept	2015 Q4	2015 Q3	2015
Revenue	$90.00K	$140.0K	$346.5K
YoY Change	24.87%	180.0%	67.06%
Cost Of Revenue	$40.00K	$50.00K	$138.0K
YoY Change	6.64%	150.0%	49.4%
Gross Profit	$50.00K	$90.00K	$208.5K
YoY Change	44.65%	200.0%	81.23%
Gross Profit Margin	55.56%	64.29%	60.18%
Selling, General & Admin	$70.00K	$50.00K	$310.5K
YoY Change	-23.33%	-37.5%	-6.85%
% of Gross Profit	140.0%	55.56%	148.87%
Research & Development		$0.00	$3.907K
YoY Change			-41.25%
% of Gross Profit		0.0%	1.87%
Depreciation & Amortization	$40.00K	$100.0K	$200.0K
YoY Change
% of Gross Profit	80.0%	111.11%	95.9%
Operating Expenses	$100.0K	$150.0K	$514.4K
YoY Change	9.53%	87.5%	51.31%
Operating Profit	-$50.00K	-$60.00K	-$305.8K
YoY Change	-11.87%	20.0%	35.99%
Interest Expense	$0.00	$0.00	$91.18K
YoY Change	-100.0%	-100.0%	21.55%
% of Operating Profit
Other Income/Expense, Net	-$30.00K	-$20.00K	-$1.748M
YoY Change	58.27%		2230.15%
Pretax Income	-$90.00K	-$1.250M	-$2.054M
YoY Change	12.5%	1983.33%	584.59%
Income Tax
% Of Pretax Income
Net Earnings	-$90.00K	-$1.250M	-$2.054M
YoY Change	18.91%	1983.33%	584.82%
Net Earnings / Revenue	-100.0%	-892.86%	-592.69%
Basic Earnings Per Share
Diluted Earnings Per Share	-$455.40	-$6.665K	-$1.879K
COMMON SHARES
Basic Shares Outstanding	197.7M shares	197.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2015
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.00K	$10.00K	$6.160K
YoY Change
Cash & Equivalents		$6.156K
Short-Term Investments
Other Short-Term Assets	$30.00K	$0.00	$1.340K
YoY Change	200.0%	-100.0%	-86.6%
Inventory	$20.00K	$11.97K	$11.97K
Prepaid Expenses
Receivables	$30.00K	$88.44K	$88.44K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$90.00K	$116.6K	$107.9K
YoY Change	263.47%	327.65%	259.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$10.00K	$8.660K
YoY Change
Total Long-Term Assets	$600.0K	$633.0K	$641.7K
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$90.00K	$116.6K	$107.9K
Total Long-Term Assets	$600.0K	$633.0K	$641.7K
Total Assets	$690.0K	$749.6K	$749.6K
YoY Change	2686.64%	2650.16%	2398.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$380.0K	$414.6K	$414.6K
YoY Change	-2.92%	6.97%	6.31%
Accrued Expenses	$130.0K	$52.61K	$52.61K
YoY Change	-56.38%	-81.6%	-81.86%
Deferred Revenue
YoY Change
Short-Term Debt	$10.00K	$30.00K	$29.22K
YoY Change	0.0%
Long-Term Debt Due	$140.0K	$100.0K	$95.00K
YoY Change	-22.22%	-44.44%	-47.22%
Total Short-Term Liabilities	$700.0K	$630.4K	$630.4K
YoY Change	-23.72%	-29.64%	-29.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$3.250K
YoY Change
Total Long-Term Liabilities	$0.00	$3.253K	$3.250K
YoY Change	-100.0%	15.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$700.0K	$630.4K	$630.4K
Total Long-Term Liabilities	$0.00	$3.253K	$3.250K
Total Liabilities	$700.0K	$633.6K	$633.6K
YoY Change	-23.87%	-29.5%	-29.6%
SHAREHOLDERS EQUITY
Retained Earnings		-$14.07M
YoY Change		16.31%
Common Stock		$1.974K
YoY Change		-90.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$20.00K	$115.9K	$115.9K
YoY Change
Total Liabilities & Shareholders Equity	$690.0K	$749.6K	$749.6K
YoY Change	2686.64%	2650.16%	2398.53%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2015
OPERATING ACTIVITIES
Net Income	-$90.00K	-$1.250M	-$2.054M
YoY Change	18.91%	1983.33%	584.82%
Depreciation, Depletion And Amortization	$40.00K	$100.0K	$200.0K
YoY Change
Cash From Operating Activities	-$40.00K	$0.00	-$155.3K
YoY Change	-33.33%	-100.0%	-29.39%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	40.00K	0.000	159.0K
YoY Change	-33.33%		-24.29%
NET CHANGE
Cash From Operating Activities	-40.00K	0.000	-155.3K
Cash From Investing Activities
Cash From Financing Activities	40.00K	0.000	159.0K
Net Change In Cash	0.000	0.000	3.650K
YoY Change		-100.0%	-136.5%
FREE CASH FLOW
Cash From Operating Activities	-$40.00K	$0.00	-$155.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2124900908	shares
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14188824	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14154917	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	35914	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	749556	USD
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	197375267	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	197375267	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2015Q3	us-gaap	Inventory Net InventoryNet	11967	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	1974	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9991	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	116556	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	633000	USD
CY2015Q3	us-gaap	Assets Assets	749556	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	414588	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	131856	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	38967	USD
CY2015Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	756	USD
CY2015Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	29221	USD
CY2015Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	95001	USD
CY2015Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3253	USD
CY2015Q3	us-gaap	Liabilities Liabilities	713642	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6156	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	88442	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2505	USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Liabilities Liabilities	898813	USD
CY2014Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2825	USD
CY2014Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2825	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	895988	USD
CY2014Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	180738	USD
CY2014Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		USD
CY2014Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	10430	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31295	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	285950	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	387575	USD
CY2014Q3	us-gaap	Assets Assets	27255	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	27255	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8656	USD
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2015Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3253	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	92349	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	710389	USD
CY2014	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	2002	USD
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2124900908	shares
CY2014Q3	us-gaap	Inventory Net InventoryNet	16094	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	27013	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	57142	USD
CY2015	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-9674	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	8100	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-155339	USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27255	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	-871558	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12101150	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11208314	USD
CY2014	us-gaap	Depreciation Depreciation		USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6650	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	302789	USD
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	30521	USD
CY2014	us-gaap	Revenues Revenues	207424	USD
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges		USD
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00014
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-299899	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75014	USD
CY2014	us-gaap	Interest Expense InterestExpense	75014	USD
CY2014	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument		USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-224885	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	339960	USD
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	36975	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3907	USD
CY2015	us-gaap	Depreciation Depreciation	200000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	514377	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-305832	USD
CY2015	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	-489759	USD
CY2015	us-gaap	Interest Expense InterestExpense	91176	USD
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1167000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1747935	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-2053767	USD
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00188
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1092768481	shares
CY2015	us-gaap	Revenues Revenues	346518	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	137973	USD
CY2015	us-gaap	Gross Profit GrossProfit	208545	USD
CY2015	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	200000	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	44738	USD
CY2015	clri	Issuance Of Common Stock And Warrants For Services Or Claims IssuanceOfCommonStockAndWarrantsForServicesOrClaims		USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	88442	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4127	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1335	USD
CY2015	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	37990	USD
CY2015	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	81000	USD
CY2015	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	40000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	158990	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3651	USD
CY2015	us-gaap	Interest Paid InterestPaid	5064	USD
CY2015	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	2000000000	shares
CY2015	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	25000000	shares
CY2015	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	2000000	USD
CY2015	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1520	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-489759	USD
CY2014	us-gaap	Interest Paid InterestPaid	5895	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8683	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	209000	USD
CY2014	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
CY2014	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2014	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	359000	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-217683	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-13071	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	49270	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-55177	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-60001	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6787	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22404	USD
CY2014	clri	Issuance Of Common Stock And Warrants For Services Or Claims IssuanceOfCommonStockAndWarrantsForServicesOrClaims	10000	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		USD
CY2014	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization		USD
CY2015Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	43325000	shares
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11188	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	-940659	USD
CY2014	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	10000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	359000	USD
CY2014	clri	Common Stock Issued In Conversion Of Preferreda Shares CommonStockIssuedInConversionOfPreferredaShares		USD
CY2014	clri	Common Stock Issued In Conversion Of Preferredc Shares CommonStockIssuedInConversionOfPreferredcShares		USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37990	USD
CY2015	clri	Common Stock Issued In Conversion Of Preferreda Shares CommonStockIssuedInConversionOfPreferredaShares		USD
CY2015	clri	Shares Issued For Conversion Of Notes Payables And Accrued Interest SharesIssuedForConversionOfNotesPayablesAndAccruedInterest	39520	USD
CY2015	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	825212	USD
CY2015	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2000000	USD
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	58517	USD
CY2014Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4520000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4520000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0.00	USD
CY2015Q1	us-gaap	Share Price SharePrice	0.08
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; padding-left: 63.35pt; font-family: 'Times New Roman';" align="justify"><font style="font-size: 10pt;"><b>USE OF ESTIMATES</b></font></p> <p style="margin: 0pt; font-family: 'times new roman';" align="justify"><font style="font-size: 10pt;"> </font></p> <p style="margin: 0pt; padding-left: 63.7pt; font-family: 'Times New Roman';" align="justify"><font style="font-size: 10pt;">In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</font></p> </div>
CY2015	us-gaap	Advertising Expense AdvertisingExpense	987	USD
CY2014Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4520000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses		USD
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.390	pure
CY2015	us-gaap	Concentration Risk Credit Risk Uninsured Deposits ConcentrationRiskCreditRiskUninsuredDeposits	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; text-indent: 63.7pt; font-family: 'Times New Roman';" align="justify"><font style="font-size: 10pt;"><b>CONCENTRATION OF CREDIT RISK</b></font></p> <p style="margin: 0pt; font-family: 'times new roman';" align="justify"><font style="font-size: 10pt;"> </font></p> <p style="margin: 0pt; padding-left: 63.35pt; font-family: 'Times New Roman';" align="justify"><font style="font-size: 10pt;">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in noninterest-bearing transaction accounts are insured up to a maximum of $<font>250,000</font> at all FDIC-insured institutions.</font></p> </div>
CY2014	clri	Effective Income Tax Rate For Deferred Tax Asset EffectiveIncomeTaxRateForDeferredTaxAsset	0.390	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050	pure
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2015Q3	clri	Receivables Factoring Discount Rate Lower Range ReceivablesFactoringDiscountRateLowerRange	0.0225	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2015Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5128000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0.00	USD
CY2015Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4621000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	2121	USD
CY2015Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5128000	USD
CY2015	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2032-12-31
CY2015Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	13149000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	507000	USD
CY2014Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2500000	shares
CY2015Q3	clri	Receivables Factoring Discount Rate Higher Range ReceivablesFactoringDiscountRateHigherRange	0.0625	pure
CY2015Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2015Q1	clri	Royalty Percentage RoyaltyPercentage	0.80	pure
CY2015Q1	clri	Royalty Percentage RoyaltyPercentage	0.20	pure
CY2015Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	25000000	shares
CY2013Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	USD
CY2015	us-gaap	Increase Decrease In Other Loans IncreaseDecreaseInOtherLoans	-594000	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050	pure
CY2015	clri	Effective Income Tax Rate For Deferred Tax Asset EffectiveIncomeTaxRateForDeferredTaxAsset	0.390	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.390	pure
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1432859	shares
CY2015Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	38000	USD
CY2015Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1520	USD
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	15287	USD
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1784	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	196.00
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	196.00
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1617	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	90.00
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	167	shares
CY2013Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	40000000	shares
CY2013Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2000000000	shares
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	90.00
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	167	shares
CY2013Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10000000	shares
CY2013Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100000	USD
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	USD
CY2015Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	216500	shares
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5000000	shares
CY2014Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	USD
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	900000	shares
CY2014Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9000	USD
CY2015Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12990	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	40000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	41610	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	43280	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	132150	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	7260	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	43673	USD
CY2015	us-gaap	Officers Compensation OfficersCompensation	8000	USD
CY2015	clri	Area Of Leased Facility AreaOfLeasedFacility	1700
CY2015	clri	Monthly Rental Cost MonthlyRentalCost	3200	USD
CY2015	clri	Annual Increase To Base Rent AnnualIncreaseToBaseRent	0.04	pure
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	51549	USD
CY2014	clri	Amount Rent Was Reduced Due To Sublease Agreement AmountRentWasReducedDueToSubleaseAgreement	30000	USD
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	197722989	shares
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Entity Registrant Name EntityRegistrantName	Cleartronic, Inc.
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001362516
CY2015	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q1	dei	Entity Public Float EntityPublicFloat	7386927	USD

Files In Submission

Name	View Source	Status
0001091818-16-000214-index-headers.html	Edgar Link	pending
0001091818-16-000214-index.html	Edgar Link	pending
0001091818-16-000214.txt	Edgar Link	pending
0001091818-16-000214-xbrl.zip	Edgar Link	pending
clri-20150930.xml	Edgar Link	completed
clri-20150930.xsd	Edgar Link	pending
clri-20150930_cal.xml	Edgar Link	unprocessable
clri-20150930_def.xml	Edgar Link	unprocessable
clri-20150930_lab.xml	Edgar Link	unprocessable
clri-20150930_pre.xml	Edgar Link	unprocessable
clri0107201610k.htm	Edgar Link	pending
ex1016.htm	Edgar Link	pending
ex1017.htm	Edgar Link	pending
ex1018.htm	Edgar Link	pending
ex1019.htm	Edgar Link	pending
ex1019001.jpg	Edgar Link	pending
ex1019002.jpg	Edgar Link	pending
ex1019003.jpg	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRI
Cleartronic, Inc. Stock $clri

2015 Q4 Form 10-K Financial Statement

#000109181816000214 Filed on January 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI Cleartronic, Inc. Stock $clri

2015 Q4 Form 10-K Financial Statement

#000109181816000214 Filed on January 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI
Cleartronic, Inc. Stock $clri